Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.

Reducing Opioids in Surgical Pain Management:
Exploring New Perioperative and Postoperative Strategies

Wednesday, April 18, 2018
5:00 - 6:00 pm ET

Register online at

The U.S. opioid epidemic continues and strategies are needed to reduce their use before and after surgery, and for long-term pain management. This webinar presented by Drs. R. Corey Waller, Jay Kuchera, Sarah E. Rebstock, and Daniel H. Sajewski is accredited for physicians, nurses, and pharmacists.

Complimentary CME & CE Credits. There is no charge for the program or certificate, but registration is required for the webinar, access to the slides, and online post-test CME assessment.

Planned and developed by Medavera, Inc. and supported by an educational grant from Cumberland Pharmaceuticals, Inc.

Medavera, Inc. has partnered with Envision to provide this program to healthcare professionals.

BOSTON (Reuters) - The U.S. Food and Drug Administration on Friday took steps to restrict what pharmaceutical ingredients large compounding pharmacies can use to manufacture drugs in bulk that do not go through the agency's approval processes.... WASHINGTON (Reuters) - U.S. President Donald Trump on Friday said his administration will be suing some drug companies as part of its fight against the opioid drug crisis, without giving more detail.... (Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.... (Reuters) - A panel of European Medicines Agency on Friday recommended against granting marketing approval to Portola Pharmaceuticals Inc's oral blood thinner, saying the benefits of the drug did not outweigh risks.... (Reuters Health) - Even people with common and often treatable mental health problems like depression and anxiety may have a harder time than patients without these diagnoses getting admitted to a high-quality nursing home, a U.S. study suggests.... (Reuters Health) - Obese people have shorter lives and even those who are just overweight spend more years living with heart disease than individuals who are a healthy weight, a U.S. study suggests.... (Reuters Health) - Even when cutting calories helps people lose weight, they may have a harder time getting rid of excess body fat if they don’t get enough sleep, a small experiment suggests.... BOSTON (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.... (Reuters) - A panel of European Medicines Agency (EMA) has recommended granting conditional marketing approval to Clovis Oncology's drug for ovarian cancer, citing anti-tumour activity.... (Reuters Health) - For women bothered by vaginal symptoms after menopause, prescription local estrogen treatments and expensive specialty lubricants may provide relief, but no more so than a dummy drug, researchers say....